Literature DB >> 15688079

Depression, antidepressants and suicidality: a critical appraisal.

Julio Licinio1, Ma-Li Wong.   

Abstract

Regulatory agencies in the United Kingdom and United States have been critically examining the possible link between suicidality and antidepressant use in children and adults, which has resulted in an FDA directive to the manufacturers of all antidepressant medications to add a 'black box' warning that describes the increased risk of suicidal behaviour in children and adolescents who take antidepressants. A crucial issue in this debate, as we discuss here, is the assessment of the capacity of antidepressants to increase suicidality over and above what is caused by the underlying disorder, major depression, which is itself the principal cause of suicide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688079     DOI: 10.1038/nrd1634

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  29 in total

Review 1.  Antidepressants and suicidality.

Authors:  Ulrich Hegerl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06       Impact factor: 5.270

2.  Venlafaxine for major depression.

Authors:  Andrea Cipriani; John R Geddes; Corrado Barbui
Journal:  BMJ       Date:  2007-02-03

Review 3.  The pharmacological management of childhood anxiety disorders: a review.

Authors:  Shauna P Reinblatt; Mark A Riddle
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

Review 4.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

Review 5.  Smoking and suicide: a brief overview.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-08-03       Impact factor: 4.492

6.  Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF-TrkB Signaling.

Authors:  Kun Li; Si Shen; Yu-Tian Ji; Xu-Yun Li; Li-San Zhang; Xiao-Dong Wang
Journal:  Neurosci Bull       Date:  2017-10-31       Impact factor: 5.203

7.  Genetic approaches identify adult pituitary stem cells.

Authors:  Anatoli S Gleiberman; Tatyana Michurina; Juan M Encinas; Jose L Roig; Peter Krasnov; Francesca Balordi; Gord Fishell; Michael G Rosenfeld; Grigori Enikolopov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

8.  Genome-wide association study of antidepressant treatment-emergent suicidal ideation.

Authors:  Andreas Menke; Katharina Domschke; Darina Czamara; Torsten Klengel; Johannes Hennings; Susanne Lucae; Bernhard T Baune; Volker Arolt; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

9.  Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats.

Authors:  Abbey L Reed; Jeffrey C Anderson; David B Bylund; Frederick Petty; Hesham El Refaey; H Kevin Happe
Journal:  Psychopharmacology (Berl)       Date:  2009-04-22       Impact factor: 4.530

Review 10.  Factors influencing behavior in the forced swim test.

Authors:  Olena V Bogdanova; Shami Kanekar; Kristen E D'Anci; Perry F Renshaw
Journal:  Physiol Behav       Date:  2013-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.